MFG
UTHR icon

MidWestOne Financial Group’s United Therapeutics UTHR Stock Holding History

MidWestOne Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.22M Buy
10,704
+1,258
+13% +$586K 0.58% 30
2025
Q3 		$3.96M Buy
9,446
+8,324
+742% +$2.8M 0.48% 45
2025
Q2 		$322K Sell
1,122
-3,582
-76% -$1.07M 0.04% 237
2025
Q1 		$1.45M Sell
4,704
-2,143
-31% -$734K 0.21% 111
2024
Q4 		$2.42M Buy
6,847
+1,289
+23% +$474K 0.34% 68
2024
Q3 		$1.99M Sell
5,558
-1,259
-18% -$425K 0.27% 79
2024
Q2 		$2.17M Sell
6,817
-2,025
-23% -$536K 0.39% 62
2024
Q1 		$2.03M Buy
8,842
+1,584
+22% +$357K 0.36% 69
2023
Q4 		$1.6M Buy
7,258
+87
+1% +$20.1K 0.3% 82
2023
Q3 		$1.62M Buy
7,171
+1,532
+27% +$353K 0.37% 66
2023
Q2 		$1.24M Sell
5,639
-422
-7% -$93.5K 0.27% 98
2023
Q1 		$1.36M Sell
6,061
-150
-2% -$37K 0.31% 80
2022
Q4 		$1.73M Sell
6,211
-332
-5% -$83.8K 0.39% 54
2022
Q3 		$1.37M Sell
6,543
-705
-10% -$158K 0.35% 61
2022
Q2 		$1.71M Sell
7,248
-145
-2% -$29.5K 0.42% 48
2022
Q1 		$1.33M Buy
+7,393
New +$1.41M 0.29% 83

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

MidWestOne Financial Group's UTHR Position: Q4 2025 in Review

MidWestOne Financial Group increased its United Therapeutics (UTHR) stake by 13% in Q4 2025, buying an estimated $586K and bringing the position to 10,704 shares worth $5.22M. The position accounts for 0.58% of the portfolio, ranked #30.

MidWestOne Financial Group first reported a position in UTHR in Q1 2022 and has held it in 16 quarters since. 838 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

  • MidWestOne Financial Group held 10,704 shares of United Therapeutics worth $5.22M as of Q4 2025.
  • MidWestOne Financial Group bought 1,258 United Therapeutics shares in Q4 2025, an estimated $586K.
  • United Therapeutics made up 0.58% of MidWestOne Financial Group's portfolio in Q4 2025, its #30 holding.
  • MidWestOne Financial Group first reported a position in United Therapeutics in Q1 2022 and has held it in 16 quarters since.
  • 838 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on MidWestOne Financial Group's 13F filing for Q4 2025, filed 12 Feb 2026.